Centessa Pharmaceuticals (CNTA) Cash from Operations (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Cash from Operations of 72224000.0 for Q1 2026, down 26.16% year-over-year from 97817145.45 in Q1 2025, and down 29.42% quarter-over-quarter from 55807000.0 in Q4 2025.
Centessa Pharmaceuticals (CNTA) Cash from Operations (2020 - 2026) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 7 years of Cash from Operations data on file, last reported at 72224000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 72224000.0, down 26.16% year-over-year; the trailing twelve-month figure through Mar 2026 was 208795000.0 (down 28.87% YoY), and the FY2025 annual result was 193817000.0, down 36.44% from the prior year.
- Cash from Operations eased to 72224000.0 in Q1 2026 per CNTA's latest filing, from 55807000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 21389000.0 in Q3 2024 and troughed at 72224000.0 in Q1 2026.
- A 5-year average of 45234352.94 and a median of 44062000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations sank 329.88% in 2022, then soared 44.67% in 2025.
- A 5-year view of Cash from Operations shows it stood at 51564000.0 in 2022, then surged by 39.78% to 31050000.0 in 2023, then plunged by 37.84% to 42800000.0 in 2024, then tumbled by 30.39% to 55807000.0 in 2025, then dropped by 29.42% to 72224000.0 in 2026.
- Business Quant data shows CNTA's Cash from Operations at 72224000.0 in Q1 2026, 55807000.0 in Q4 2025, and 58312000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Centessa Pharmaceuticals | 6.10 Bn | 6.10 Bn | - | -72.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -72.22 Mn |
| Mar 31, 2026 | -72.22 Mn |
| Dec 31, 2025 | -55.81 Mn |
| Dec 31, 2025 | -55.81 Mn |
| Sep 30, 2025 | -58.31 Mn |
| Sep 30, 2025 | -58.31 Mn |
| Jun 30, 2025 | -22.45 Mn |
| Jun 30, 2025 | -22.45 Mn |
| Mar 31, 2025 | -57.25 Mn |
| Mar 31, 2025 | -57.25 Mn |
| Dec 31, 2024 | -42.80 Mn |
| Dec 31, 2024 | -42.80 Mn |
| Sep 30, 2024 | -21.39 Mn |
| Sep 30, 2024 | -21.39 Mn |
| Jun 30, 2024 | -40.58 Mn |
| Jun 30, 2024 | -40.58 Mn |
| Mar 31, 2024 | -37.29 Mn |
| Mar 31, 2024 | -37.29 Mn |
| Dec 31, 2023 | -31.05 Mn |
| Dec 31, 2023 | -31.05 Mn |